The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of lapatinib (L) plus trastuzumab (T) and aromatase inhibitor (AI) vs T+AI vs L+AI in postmenopausal women (PMW) with HER2+, HR+ metastatic breast cancer (MBC): ALTERNATIVE.
 
William John Gradishar
No Relationships to Disclose
 
Roberto Hegg
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Hanmi; Novartis; Spectrum Pharmaceuticals
 
In Hae Park
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; Lilly; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
Sarah Kenny
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Severine Sarp
Employment - Novartis
 
Lisa Williams
Employment - Novartis
 
Miguel A. Izquierdo
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Stephen R. D. Johnston
Consulting or Advisory Role - AstraZeneca; Novartis; OBI Pharma; Roche
Speakers' Bureau - OBI Pharma; Pfizer; Puma Biotechnology
Research Funding - Pfizer